IFP Advisors’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-25
| Closed | -$146 | – | 5052 |
|
|
2025
Q1 | $146 | Buy |
25
+18
| +257% | +$95 | ﹤0.01% | 3756 |
|
|
2024
Q4 | $160 | Buy |
+7
| New | +$32 | ﹤0.01% | 3845 |
|
|
2019
Q1 | – | Sell |
-70
| Closed | -$3K | – | 3538 |
|
|
2018
Q4 | $3K | Hold |
70
| – | – | ﹤0.01% | 3081 |
|
|
2018
Q3 | $4K | Hold |
70
| – | – | ﹤0.01% | 3341 |
|
|
2018
Q2 | $6K | Hold |
70
| – | – | ﹤0.01% | 3198 |
|
|
2018
Q1 | $5K | Hold |
70
| – | – | ﹤0.01% | 3204 |
|
|
2017
Q4 | $5K | Sell |
70
-765
| -92% | -$61.2K | ﹤0.01% | 3252 |
|
|
2017
Q3 | $76K | Sell |
835
-150
| -15% | -$12.8K | ﹤0.01% | 1720 |
|
|
2017
Q2 | $73K | Sell |
985
-620
| -39% | -$49.7K | ﹤0.01% | 1720 |
|
|
2017
Q1 | $150K | Sell |
1,605
-710
| -31% | -$64.3K | 0.01% | 1268 |
|
|
2016
Q4 | $168K | Sell |
2,315
-440
| -16% | -$37.7K | 0.01% | 1143 |
|
|
2016
Q3 | $288K | Sell |
2,755
-2,115
| -43% | -$191K | 0.02% | 834 |
|
|
2016
Q2 | $359K | Buy |
+4,870
| New | +$331K | 0.02% | 688 |
|
|
2016
Q1 | – | Sell |
-2,760
| Closed | -$186K | – | 3520 |
|
|
2015
Q4 | $186K | Buy |
+2,760
| New | +$148K | 0.01% | 860 |
|
Other funds holding NVRO
IFP Advisors's NVRO Position: Q2 2025 in Review
IFP Advisors sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 25 shares — an estimated $146 sold.
IFP Advisors first reported a position in NVRO in Q4 2015 and held it in 14 quarters. The position peaked at $359K in Q2 2016. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- IFP Advisors reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- IFP Advisors sold 25 NEVRO CORP. shares in Q2 2025, an estimated $146.
- IFP Advisors first reported a position in NEVRO CORP. in Q4 2015 and held it in 14 quarters.
- IFP Advisors's NEVRO CORP. position peaked at $359K in Q2 2016.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.